Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Determining the Risk of Developing Contrast-Induced Nephopathy

Clinical trial NCT00693329 · COMPLETED

Trial details

NCT number: NCT00693329
Sponsor: Abbott RDx Cardiometabolic
Status: COMPLETED
Study type: OBSERVATIONAL

Cardiovascular Surgery With Coronary Angiography

Start date: 2008-03-01
Primary completion: 2009-06-01
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.